2017
DOI: 10.1111/jog.13271
|View full text |Cite
|
Sign up to set email alerts
|

Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation

Abstract: AimTo examine the usefulness of the neutrophil : lymphocyte (N/L) ratio as a cost‐effective and simple diagnostic marker of mature cystic teratoma (MCT) with malignant transformation (MT).MethodsA retrospective chart review was performed between 1998 and 2013 of 12 MCT patients with MT and between 2009 and 2013 of 130 patients with benign MCT. Data were collected on age, tumor size, white blood cell count with differential counts, tumor marker levels, and presenting features.ResultsOlder age, greater tumor siz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 21 publications
0
7
0
Order By: Relevance
“…Six studies were excluded from tabulation and analysis after reading the full text [13,[18][19][20][21][22]. Among them, three were excluded due to insufficient data [18][19][20][21]. Finally, Sagi-Dain et al…”
Section: Excluded Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Six studies were excluded from tabulation and analysis after reading the full text [13,[18][19][20][21][22]. Among them, three were excluded due to insufficient data [18][19][20][21]. Finally, Sagi-Dain et al…”
Section: Excluded Studiesmentioning
confidence: 99%
“…included patients with benign diseases and did not report separate outcomes for those with MCT whereas Wang et al enrolled only patients with torsion in their study group and were both excluded [13][14][15][16][17][18][19][20][21][22].…”
Section: Excluded Studiesmentioning
confidence: 99%
“…SCTs can express a diversity of serum tumor markers such as elevated AFP, CEA, CA72-4, and CA19-9 [ 17 20 ] and these tumor markers are helpful in identifying SCT in clinical practice. Especially, the CA19-9-positive rates in immature, mature, and malignant SCTs have been reported as 57%, 57%, and 48.6%, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…We can only depend on some risk factors as follow: i) postmenopausal age; ii) diameter more than 10cm or growing rapidly; iii) elevated serum tumor markers especially SCC antigen and CA125; iv) the presence of a solid component that extends transmurally and invades the adjacent structures in magnetic resonance imaging (MRI). [1,3,[5][6][7] Cases with these factors usually had a worse prognosis. [4] Our patient is a postmenopausal woman with a 142*115mm mass and mildly elevated the level of tumor markers.…”
Section: Risk Factors Of Malignant Transformation In Omctsmentioning
confidence: 99%